Table 1.

The clinical features of patients with CD56+ ALCL in the current study

Case No.	Age (y)/Sex	Sites of involvement	Stage	B symptoms	LDH level	Treatment	Status	Follow-up time (months)
1	19/M	Soft tissue of waist	IE	No	Normal	CT	Alive	49
2	63/M	Skin of right lower extremity; right inguinal lymph nodes	IIE	No	Normal	CT (CHOP)	Alive	51
3	60/M	Right anterior inferior gingiva	IE	No	Normal	CT (CHOP)	Alive a	69
4	52/F	Left iliac bone	NA	NA	NA	NA	NA	NA
5	13/F	Left breast	IE	No	Normal	CT (CHOP)	Alive	77
6	20/M	Parathoracic soft tissue	IE	No	Normal	CT (CHOP)	Alive	79
7	25/F	Right breast	IE	No	Normal	CT + RT	Alive	86
8	26/M	Left axillary soft tissue	IE	Yes	NA	CT (CHOP) + RT	Alive	92
9	23/M	Right cervical lymph nodes	I	Yes	NA	CT (CHOP)	Alive	37
10	35/M	Cervical lymph node	I	Yes	Normal	CT (CHOP) + RT	Alive	104
11	15/M	Nasopharynx, posterior nares; masses on the back, left thigh and left axilla	IVE	Yes	Normal	CT (CHOP) + RT	Alive	114
12	17/M	Nasopharynx, oropharynx, posterior nares; cervical lymph nodes	IIE	Yes	Normal	L-Asparaginase +DICE	Dead	0.5
13	47/M	Skin lesions of left leg, left thigh and right leg	IVE	No	Normal	CT + RT+ ASCT	Alive	97
14	67/M	Multiple lymphadenopathy of neck, axilla, subclavian and retroperitoneal; tumorous pleural fluid and ascites	IV	No	high	refusal to treatment	Dead	22
15	27/M	Soft tissue of right thigh root	IE	No	NA	CT (CHOP)	Alive	40
16	8/F	Right nasopharynx, right upper neck, the anterior area of the right ear	IIE	NA	Normal	CT	Alive	95
17	19/F	Soft tissue of the right chest wall, abdominal wall and left groin	IVE	No	NA	NA	Alive	1
18	22/M	Left cervical lymph nodes	NA	Yes	NA	NA	Dead	1

^a Recurrence 24 months after original diagnosis

CT chemotherapy, but regimen unavailable, CT (CHOP) chemotherapy with cyclophosphamide, doxorubicin, vincristine and prednisone, RT radiation therapy, DICE chemotherapy with dexamethasone, ifosfamide, cisplatin and etoposide, ASCT autologous stem cell transplantation, NA not available